Allosteric hemoglobin modifiers to decrease oxygen affinity in blood
US5432191A · kind A · utility
26Cited by
4References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 1993 |
| Grant date | Jul 11, 1995 |
| Priority date | — |
| Expiry date | Jul 30, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The compounds are capable of acting on hemoglobin in whole blood. In addition, the compounds can maintain the oxygen affinity in blood during storage and can restore the oxygen affinity of outdated blood.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.